SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-24-022025
Filing Date
2024-07-02
Accepted
2024-07-02 18:12:26
Documents
1
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 4 rdgdoc.html 4  
1 FORM 4 rdgdoc.xml 4 7638
  Complete submission text file 0001437749-24-022025.txt   9033
Mailing Address 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091
Business Address 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091 8473880349
Monopar Therapeutics (Issuer) CIK: 0001645469 (see all company filings)

IRS No.: 320463781 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091
Business Address
Cittadine Andrew (Reporting) CIK: 0001863624 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39070 | Film No.: 241097524